Drug companies control news with $$$$ in ads The Deeper

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
127
Drug companies control news with $$$$ in ads

The Deeper Reason For Drug Ads On Television

https://www.naturalblaze.com/2018/03/deeper-r...ision.html

By Jon Rappoport

Television viewers are inundated with drug ads from Big Pharma. It’s a flood.

Have you ever heard of these drugs? Otezla, Xeljanz, Namzaric, Keytruda, Breo, Cosentyz? Not likely. If you have, do you know what conditions they treat? Highly unlikely. But there they are, splashed in commercials.

Why? Who is going to remember to ask their doctor whether these and other obscure meds are right for them?

What’s going on here?

The answer is: IT DOESN’T MATTER WHAT DRUGS ARE BEING ADVERTISED.

If Pharma can pay enough TOTAL money for ads, for ALL drugs, and dominate the allotted TV time for commercials, it can control the news—and that is exactly what it wants to do.

Pharmaceutical scandals are everywhere. Reporting on them, wall to wall, isn’t good for the drug business. However, as an industry ponying up billions of dollars for TV ads, Pharma can limit exposure and negative publicity. It can (and does) say to television networks: If you give us a hard time on the news, we’ll take our ad money and go somewhere else. Boom. End of problem.

Face it, the billions of dollars Pharma is paying for TV ads are a drop in the bucket, compared with its profits gained from selling the drugs. The ads are a good investment. As a bribe.

Control the news.

There is another reason for the insane flood of TV drug ads:

By their sheer number, they convince viewers that medical drugs (no matter what they are) are absolutely necessary.

Hour by hour, viewers numbly watch drug commercial after commercial. The overall message is: To keep illness from your door, to cure illness, to alleviate illness, you must take these medicines. THIS IS LIFE IN THE 21ST CENTURY. You’re all sick, and you need help, and this is the ONLY kind of help there is.

The drug companies could invent names of fake drugs that don’t even exist, advertise them in a cascade on television, with the same intent. DRUGS ARE AS VITAL TO LIFE AS WATER OR AIR.
But what about all those dire warnings of side effects from the drugs? By law, the companies must include them in their commercials. Well, the companies have calculated that, on balance, the stark, front-line, unending message of DRUGS, DRUGS, AND MORE DRUGS will outweigh the warnings in viewers’ minds.

If the television audience is nailed with the idea that they can’t escape; that their health always hangs in the balance; that dire illnesses are always waiting in the shadows to strike; that the slightest ache or pain could be a precursor to a crippling or fatal disease; and drugs are the only solution and protection—they’re going to overlook the warnings about side effects.

ALL IN ALL, DRUG ADS ARE NEWS.

That’s the approach. Pharma is blasting out 24/7 news asserting modern medicine’s central and commanding role in the life of every human.

It’s a gigantic and stupendous piece of mind control, but when did that ever stop tyrants from inventing reality for the masses?

Implicit in “ask your doctor if drug X is right for you,” is the message: “go to your doctor.” That’s the key. If the ads can put a viewer into the system, he will be diagnosed with something, and he’ll be given a drug for it.

So the drug ads are also promotions for doctors, who are the arbiters and the decision makers. Some kind of medical need (drugs) always exists—and the doctor will tell you what it is. And all patients should OBEY. Even if, in the process, they go broke.

Take the case of Opdivo, a drug that treats squamous non-small cell lung cancer. Cost? $12,500 a month. Patients on Medicare will pay $2500 a month out of their own pockets. And the result?

Wall St. Journal: “In the clinical study on which the Opdivo ad bases its claims, the drug extended median patient survival to 9.2 months from the start of treatment…”

The cancer patient pays $22,500 for nine months of survival, during which the suffering continues, and then he dies.

The ad isn’t mentioning THAT.

The ad relies on the doctor to convince the patient to go along with this lunatic program.

The author of two explosive collections, THE MATRIX REVEALED and EXIT FROM THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at www.nomorefakenews.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WaterField Launches Shield Case for Steam Frame

Updated Category News Views 19

WaterField Shields Your VR Experience on the Move Picture this: You're deep into virtual reality gaming, and your setup is finally on point. The big but often overlooked question is—how do you lug this powerful tech around without turning it into a jumbled mess? Enter WaterField Designs with their latest creation, the Shield Case meant for Valve's Steam Frame VR...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 0

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
U&I Ventures Raises $32.237M for AI Infrastructure

Updated Category News Views 54

U&I Ventures Stirs the Pot with Its Debut Fund Here's what I see brewing in the tech sector: when 1,800 top-notch tech leaders come together, you know something's up. U&I Ventures has locked in a $32.237 million fund to tackle AI-native infrastructure in security and engineering. Now, that's a firm that ain't messing around, pulling in the big guns for a big venture. The...

Continue Reading
BJ's Brews a New Dessert Innovation with Pizookie

Updated Category News Views 37

Banana Bread Meets Nutella in BJ's Latest Pizookie Right off the bat, let's cut to the heart of this dessert innovation. BJ's Restaurant & Brewhouse, traded under NASDAQ:BJRI, has fired up its dessert menu with something new: the Nutella® Gone Bananas Pizookie®. This isn't just another sweet treat—it’s a bold move, and if you're wondering why, you're in good...

Continue Reading
New Insurance Rules Limit Public Input Amid Controversy

Updated Category News Views 38

Insurance Rules Change the Game, Yet Again When the bureaucracy tightens its grip, consumers often pay the price. California's recent twist in insurance regulations does just that, taking a red pen to public involvement and paving the road for insurers to hike rates with less interference. A Peek Behind the Curtain This new maneuver by the Department of Insurance...

Continue Reading
CallRail's New Insight Tool: Navigating the Competitive Landscape

Updated Category News Views 11

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Continue Reading
Pencil Reinvention Aims to Reduce Classroom Waste

Updated Category News Views 20

Sharpen Those Ideas: Reinventing the Humble Pencil Every classroom has 'em: pencils chewed up faster than a kid chomping through bubblegum. This ain't new. But dig this—a Chicago teacher's coming in hot with a tweak to extend pencil life. How? By addressing the ol' crumbly eraser issue. You know, the kind that vanishes into thin air right when you need it most. So,...

Continue Reading
Bechtel's $1M Push for Wyoming's Skilled Trades Future

Updated Category News Views 220

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 0

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading
Concurrence Expands Reach With Microsoft Marketplace

Updated Category News Views 22

Concurrence's Big Move into Microsoft's Court From the bustling streets of New York to the mighty tech avenues of Seattle, Concurrence is making waves that could leave a whale-sized impact on the healthcare sector. As of today, their Health World Model and snazzy AI agents have entered the Microsoft Marketplace, marking a significant leap forward. For the uninitiated,...

Continue Reading

Top 5 Most Recently Viewed Articles

Cellebrite Reports Historic Q3 Results with Strong Growth

Updated Category News Views 49

Historic Performance in Q3 2024 Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, has announced its impressive financial performance for the third quarter of 2024, generating revenue of $106.9 million. This achievement signifies the company's first-ever quarter with revenue surpassing the $100 million mark. The robust growth reflects a 27%...

Continue Reading
Exploring the Artistry of María Magdalena Campos-Pons: A Retrospective

Updated Category News Views 169

María Magdalena Campos-Pons at the Frist Art Museum For nearly four decades, María Magdalena Campos-Pons has built a body of work that moves fluently across photography, video, painting, and performance. Her exhibition, Behold, gathers that breadth at the Frist Art Museum and presents it with care. It looks back, it looks forward, and it offers new works and multimedia...

Continue Reading
Reed's Inc. Prepares for Exciting Financial Insights Call

Updated Category News Views 112

Reed's Inc. Announces Upcoming Conference Call NORWALK, Conn. – Reed's, Inc. (OTCQX: REED) is set to host a much-anticipated conference call to discuss its financial outcomes for the recent quarter. The event will take place on a Wednesday morning, where the management team will share valuable insights into the company's financial performance. Details of the Conference...

Continue Reading
MaidCentral Enhances Maid Brigade’s Efficiency in Cleaning Sector

Updated Category News Views 197

MaidCentral Partners with Maid Brigade MaidCentral has officially joined forces with Maid Brigade, a significant player in the residential cleaning industry, to provide an enhanced business management solution tailored specifically for Maid Brigade’s franchises. This collaboration represents a key step in ensuring operational excellence and improved customer...

Continue Reading
BOS Unveils New Wiring and Cabling Offerings for Clients

Updated Category News Views 224

BOS Launches New Wiring and Cabling Product Line BOS Better Online Solutions Ltd. (NASDAQ: BOSC), a leader in supply chain technology integration, has embarked on an exciting journey with the introduction of its Wiring and Cabling product line. This recent venture within the company's Supply Chain Division marks a significant expansion in their product portfolio....

Continue Reading